Figure 1
From: Effect of pioglitazone treatment in a patient with secondary multiple sclerosis
Axial T1-weighted fluid-attenuated inversion recovery (FLAIR) MRI images showing confluent demyelination. MRIs were taken at 10 months (left) and at 18 months (right) after initiation of treatment with pioglitazone. Similar axial sections are shown for the two time points.